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Abstract Cytokine-induced prostaglandin generation in rat
mesangial cells has been suggested to be dependent on the
expression of secretory phospholipase A2 (sPLA2). In the present
study, we investigated the possible involvement of Ca2+-
independent phospholipase A2 (iPLA2) in the generation. The
results showed that bromoenol lactone, a relatively selective
iPLA2 inhibitor, significantly attenuated prostaglandin E2
generation induced by interleukin-1L and dibutyryl cAMP in
parallel with the inhibition of iPLA2 activity. However, the
inhibitor did not affect sPLA2 release upon stimulation, activities
of sPLA2 or cytosolic phospholipase A2, or Ca2+ ionophore-
induced arachidonic acid liberation. These results suggest that
prostaglandin E2 generation upon stimulation may be partially
mediated by iPLA2 in addition to sPLA2.
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1. Introduction
Phospholipase A2 (PLA2) plays a central role in providing
arachidonic acid, a precursor for prostaglandins and leuko-
trienes, through the hydrolysis of membrane glycerophospho-
lipids [1]. Among numerous types of mammalian PLA2s, stim-
ulus-induced arachidonic acid liberation is thought to be
mediated by group IIA or V secretory PLA2 (sPLA2), or by
group IV cytosolic PLA2 (cPLA2) [2^4]. The sPLA2 is released
from the intracellular store upon stimulation or through the
expression of the sPLA2 protein, and subsequently hydrolyzes
membrane phospholipids [2]. On the other hand, the hydro-
lytic action of cPLA2 is regulated by Ca2-dependent trans-
location to membranes and by mitogen-activated protein kin-
ase-catalyzed phosphorylation with an increase in cPLA2
activity [4]. In contrast to these PLA2s, group VI Ca2-inde-
pendent PLA2 (iPLA2) has been suggested to contribute to
phospholipid remodeling [5]. However, the role of iPLA2 in
stimulus-induced arachidonic acid liberation remains to be
elucidated.
Arachidonic acid liberation induced by Ca2-mobilizing ag-
onists like platelet-activating factor rapidly plateaus and oc-
curs in parallel with transient intracellular Ca2 elevation and
cPLA2 translocation [6,7]. In contrast, arachidonic acid liber-
ation induced by proin£ammatory cytokines, such as interleu-
kin-1L and tumor necrosis factor, continues for a relatively
long time and occurs in parallel with the expression of sPLA2
[8,9]. The possible contribution of sPLA2 to the continual
arachidonic acid liberation has been well investigated with
rat mesangial cells upon stimulation with cytokines and/or
cAMP-elevating reagents [10^13]. Stimulation of the cells
with interleukin-1L has been shown to drastically increase
prostaglandin E2 (PGE2) and sPLA2 16^24 h after stimulation
[10]. An inhibitor of or an antibody against sPLA2 suppresses
the PGE2 generation by 50^70% [11]. The remaining PGE2
generation might be dependent on the hydrolytic action of
cPLA2, because an increase in cPLA2 activity has also been
observed after the stimulation period [12]. Furthermore, a
recent report has shown that addition of sPLA2 to the cells
induces the phosphorylation of cPLA2, probably through pro-
tein kinase C activation [13]. However, it is unclear whether or
not interleukin-1L sustains the intracellular Ca2 elevation
needed for cPLA2 activation during such a long period.
Therefore, we assumed that iPLA2 may also be involved in
the cytokine-induced PGE2 generation. In the present study,
to examine this possibility, we studied the e¡ect of bromoenol
lactone (BEL), a relatively speci¢c iPLA2 inhibitor [14,15], on
PGE2 generation in rat mesangial cells stimulated with inter-
leukin-1L and dibutyryl cAMP.
2. Materials and methods
2.1. Materials
Interleukin-1L was obtained from Collaborative Biomedical Prod-
ucts (Bedford, MA, USA). Dibutyryl cAMP was from Sigma (St.
Louis, MO, USA), BEL from Cayman Chemical (Ann Arbor, MI,
USA), and ionomycin from Calbiochem (La Jolla, CA, USA).
[3H]Arachidonic acid (100 Ci/mmol), 1-palmitoyl-2-[14C]linoleoyl-sn-
glycero-3-phosphoethanolamine (55 mCi/mmol), 1,2-dipalmitoyl-sn-
glycero-3-[choline-methyl-14C]phosphocholine (159 mCi/mmol), and
1-stearoyl-2-[3H]arachidonoyl-sn-glycero-3-phosphocholine (160 Ci/
mmol) were obtained from New England Nuclear (Boston, MA,
USA).
2.2. Cell culture
Glomerular mesangial cells were obtained from a culture of glomer-
uli isolated from Sprague-Dawley rats, and grown in RPMI 1640
supplemented with 20% heat-inactivated fetal bovine serum, 100 U/
ml penicillin, 100 Wg/ml streptomycin, 5 Wg/ml insulin, 5 Wg/ml trans-
ferrin, and 5 ng/ml sodium selenite [16]. Con£uent mesangial cells
(passages 3^8) were made quiescent by incubating them in RPMI
1640 containing 0.1 mg/ml bovine serum albumin for 24 h, and
then used for the following experiments.
2.3. Measurement of PGE2 generation and arachidonic acid liberation
The quiescent cells in 35 mm dishes were incubated with
[3H]arachidonic acid (0.5 WCi/ml) for 24 h. The labeled cells were
washed and incubated with BEL at 37‡C for 1 h in 1 ml of RPMI
1640 containing 0.1 mg/ml bovine serum albumin. After the medium
had been removed, the cells were stimulated in fresh medium. Lipids
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in the medium and the cells were extracted [16], and separated by thin-
layer chromatography on a silica gel G plate with the following devel-
opment systems: for the analysis of arachidonic acid, petroleum ether/
diethyl ether/acetic acid (40:40:1, v/v/v); and for the analysis of
PGE2, an upper phase of ethyl acetate/isooctane/acetic acid/H2O
(9:5:2:10, v/v/v/v). The area corresponding to each lipid was scraped
o¡ and the radioactivity was determined by liquid scintillation count-
ing.
2.4. Assay for sPLA2 activity
The quiescent cells in 35 mm dishes were treated with BEL, and
then the medium was removed. The cells were stimulated with inter-
leukin-1L and dibutyryl cAMP in 1 ml of fresh medium. After the
medium had been centrifuged, the supernatant (50 Wl), as an enzyme
source, was incubated with 2 WM 1-palmitoyl-2-[14C]linoleoyl-sn-glyc-
ero-3-phosphoethanolamine at 37‡C for 1 h in the presence of 5 mM
CaCl2 and 100 mM Tris-HCl (pH 8.5). [14C]Linoleic acid liberated
was determined as described previously [17].
2.5. Assays for iPLA2 and cPLA2 activity
The quiescent cells in 100 mm dishes were treated with BEL at 37‡C
for 1 h. The cells were scraped o¡ and washed with 340 mM sucrose,
2 mM EGTA, 100 WM leupeptin, 100 WM p-(amidinophenyl)meth-
anesulfonyl £uoride, and 10 mM HEPES (pH 7.4). After lysis of
the cells by sonication, the lysate was centrifuged at 100 000Ug for
30 min. The supernatant (10 Wg protein) obtained was treated with
5 mM dithiothreitol at 37‡C for 10 min to inhibit sPLA2 activity. For
the iPLA2 assay, the supernatant was incubated with a mixture of 1,2-
dipalmitoyl-sn-glycero-3-[choline-methyl-14C]phosphocholine and the
unlabeled compound (2.5 mCi/mmol, 100 WM) at 37‡C for 1 h in
the presence of 5 mM EDTA, 800 WM Triton X-100 and 50 mM
HEPES (pH 7.5). For the cPLA2 assay, the supernatant was incu-
bated with a mixture of 1-stearoyl-2-[3H]arachidonoyl-sn-glycero-3-
phosphocholine and the unlabeled compound (0.5 Ci/mol, 2 WM) at
37‡C for 1 h in the presence of 5 mM CaCl2 and 100 mM Tris-HCl
(pH 8.5). After lipid extraction, [14C]lysophosphatidylcholine gener-
ated or [3H]arachidonic acid liberated was determined by thin-layer
chromatography using chloroform/methanol/H2O (65:35:6, v/v/v) or
petroleum ether/diethyl ether/acetic acid (40:40:1, v/v/v) as the devel-
opment system, respectively. The radioactivity was determined and
the enzyme activity was calculated.
3. Results
As shown in Fig. 1A, stimulation of rat mesangial cells with
1 nM interleukin-1L and 1 mM dibutyryl cAMP induced
PGE2 generation time-dependently, which had progressively
increased by 24 h after the stimulation. The increase in
PGE2 was found to be signi¢cantly attenuated by pretreat-
ment with 5 WM BEL, a relatively selective iPLA2 inhibitor.
The inhibitory e¡ect of BEL occurred in a dose-dependent
manner, and 5 WM BEL suppressed the PGE2 generation by
about 40% (Fig. 1B). To determine whether or not this inhib-
itory e¡ect of BEL is due to suppression of cyclooxygenase
activity, we examined the e¡ect of BEL on the conversion of
exogenous arachidonic acid to PGE2. The addition of
[3H]arachidonic acid to mesangial cells resulted in an increase
in [3H]PGE2. However, 10 WM BEL did not a¡ect the increase
in PGE2 caused by exogenous arachidonic acid in stimulated
or intact cells (data not shown).
Fig. 2A illustrates the inhibitory e¡ect of BEL on iPLA2
activity in rat mesangial cells. When the cells were treated
with BEL (5^20 WM), iPLA2 activity in the supernatant de-
rived from the cell lysate was markedly inhibited. Under our
experimental conditions, the addition of CaCl2 to the assay
system for iPLA2 activity did not facilitate the increase in
lysophosphatidylcholine, a product generated by PLA2, indi-
cating that the increase in the product in our assay system
re£ects iPLA2 activity. Thus, we con¢rmed that BEL actually
suppressed iPLA2 activity. In rat mesangial cells, PGE2 gen-
eration induced by cytokines has been suggested to be depend-
ent on the expression of sPLA2 [10,11]. Therefore, we deter-
mined the e¡ect of BEL on sPLA2 release upon stimulation.
As shown in Fig. 2B, however, treatment of the cells with
BEL (10, 20 WM) did not a¡ect an increase in sPLA2 activity
in the extracellular medium in response to 1 nM interleukin-
1L and 1 mM dibutyryl cAMP. Furthermore, even though the
medium of the stimulated cells was treated with 20 WM BEL
for 30 min, sPLA2 activity in the medium was not a¡ected
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Fig. 1. E¡ect of BEL on PGE2 generation induced by interleukin-1L
and dibutyryl cAMP. A: [3H]Arachidonic acid-labeled mesangial
cells were treated with (squares) or without (circles) 5 WM BEL for
1 h. The cells in fresh medium were stimulated with (closed sym-
bols) or without (open symbols) 1 nM interleukin-1L and 1 mM di-
butyryl cAMP for the indicated periods. B: [3H]Arachidonic acid-la-
beled mesangial cells were treated with various concentrations of
BEL for 1 h. The cells in fresh medium were stimulated with (closed
symbols) or without (open symbols) 1 nM interleukin-1L and 1 mM
dibutyryl cAMP for 24 h. [3H]PGE2 generated was determined as
described in Section 2.3. Data represent the means ( þ S.E.M.) for
two or three separate experiments performed in duplicate.
Fig. 2. E¡ect of BEL on iPLA2 activity (A) and sPLA2 release (B).
A: Mesangial cells were treated with various concentrations of BEL
for 1 h. The activity of iPLA2 in the supernatant derived from the
cells was determined as described in Section 2.5. B: Mesangial cells
were treated with BEL and then stimulated as in Fig. 1B. The activ-
ity of sPLA2 in the extracellular medium was determined as de-
scribed in Section 2.4. Data represent the means ( þ S.E.M.) for two
or three separate experiments performed in duplicate.
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(4327 þ 173 dpm and 4453 þ 254 dpm for the activities in the
untreated and BEL-treated medium, respectively, mean
þ S.E.M., n = 3).
Recently, exogenous sPLA2 was shown to induce the phos-
phorylation of cPLA2 [13], suggesting the involvement of
cPLA2 in sPLA2-dependent PGE2 generation. Therefore, the
e¡ect of BEL on cPLA2 activity was determined. However,
treatment with BEL (10, 20 WM) had no e¡ect on cPLA2
activity in rat mesangial cells (Fig. 3A). Furthermore, we
showed that 10 WM BEL did not a¡ect ionomycin-induced
arachidonic acid liberation, which is presumably catalyzed
by cPLA2 (Fig. 3B).
4. Discussion
In order to investigate the possible involvement of iPLA2 in
stimulus-induced arachidonic acid liberation, we examined
whether or not BEL, a relatively selective iPLA2 inhibitor,
a¡ects PGE2 generation in rat mesangial cells stimulated
with interleukin-1L and dibutyryl cAMP. In the present study,
we found that BEL decreased PGE2 generation upon the
stimulation by about 40% (Fig. 1) in parallel with inhibition
of iPLA2 activity (Fig. 2A). This suggests that BEL-sensitive
iPLA2 may be partially implicated in the PGE2 generation.
The stimulation of rat mesangial cells with interleukin-1L and/
or cAMP-elevating reagents has been shown to induce PGE2
generation in parallel with the expression of sPLA2 [10]. Fur-
thermore, an inhibitor of or an antibody against sPLA2 has
been reported to attenuate the PGE2 generation by 50^70%
[11]. These ¢ndings clearly suggest the contribution of sPLA2
to the generation. We further demonstrated that BEL did not
a¡ect sPLA2 release (Fig. 2B) or its activity, indicating that
the inhibition of PGE2 generation by BEL does not result
from impairment of intracellular signaling leading to the
sPLA2 expression or the hydrolytic action of sPLA2 released.
Therefore, it is possible that PGE2 generation induced by
interleukin-1L and dibutyryl cAMP is mediated by iPLA2 in
addition to sPLA2.
Previously, it was shown that interleukin-1L induces an in-
crease in cPLA2 activity at the time when sPLA2 expression is
su⁄ciently observed [12]. A recent report has shown that
exogenous sPLA2 induces the phosphorylation of cPLA2
through protein kinase C activation [13]. In that report, there-
fore, it was proposed that interleukin-1L-induced PGE2 gen-
eration may be mediated by cPLA2, which is activated by
sPLA2 released. Although it is unclear whether or not
sPLA2-activated cPLA2 actually participates in PGE2 gener-
ation induced by interleukin-1L and dibutyryl cAMP, the
present study demonstrated that BEL had no e¡ect on cPLA2
activity or ionomycin-induced arachidonic acid liberation
(Fig. 3). Therefore, based on the present results, we suggest
that BEL attenuates PGE2 generation induced by interleukin-
1L and dibutyryl cAMP probably through inhibition of iPLA2
activity without suppression of the actions of sPLA2 and
cPLA2.
Several types of iPLA2s have been detected in a variety of
cells and tissues [18]. Among the iPLA2s, 80 kDa group VI
iPLA2 has been puri¢ed, sequenced, and well characterized
[19,20]. It has been proposed that group VI iPLA2 does not
participate in stimulus-induced arachidonic acid liberation,
because BEL or an antisense oligonucleotide for the iPLA2
does not a¡ect platelet-activating factor-induced arachidonic
acid liberation [21,22]. In contrast, the results we obtained
here suggest the involvement of iPLA2 in arachidonic acid
liberation upon stimulation, although it is unclear whether
or not iPLA2 detected in rat mesangial cells is identical to
group VI iPLA2. This discrepancy may be due to di¡erences
in the types of agonists used. Platelet-activating factor is one
of the Ca2-mobilizing agonists, while interleukin-1L and di-
butyryl cAMP are not. Recent studies with iPLA2 inhibitors
including BEL have also suggested the contribution of iPLA2
to stimulus-induced arachidonic acid liberation [23,24]. In
Fas-stimulated human leukemic U937 cells, however, iPLA2
activity did not change upon the stimulation [24]. We also
observed no change in iPLA2 activity in stimulated rat me-
sangial cells (data not shown). Thus, the mechanism under-
lying acceleration of the iPLA2 action has not been elucidated
at present. Further studies will focus on the regulation of the
hydrolytic action of iPLA2 upon stimulation.
In conclusion, based on the present results, we propose that
BEL-sensitive iPLA2 may be partially involved in PGE2 gen-
eration induced by interleukin-1L and dibutyryl cAMP in rat
mesangial cells.
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